A decade of machine learning-based predictive models for human pharmacokinetics: Advances and challenges
- Authors
- Danishuddin; Kumar, Vikas; Faheem, Mohammad; Lee, Keun Woo
- Issue Date
- Feb-2022
- Publisher
- Elsevier BV
- Keywords
- Pharmacokinetics; QSAR; Chemical Big Data; Drug development
- Citation
- Drug Discovery Today, v.27, no.2, pp 529 - 537
- Pages
- 9
- Indexed
- SCIE
SCOPUS
- Journal Title
- Drug Discovery Today
- Volume
- 27
- Number
- 2
- Start Page
- 529
- End Page
- 537
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/72535
- DOI
- 10.1016/j.drudis.2021.09.013
- ISSN
- 1359-6446
1878-5832
- Abstract
- Traditionally, in vitro and in vivo methods are useful for estimating human pharmacokinetics (PK) parameters; however, it is impractical to perform these complex and expensive experiments on a large number of compounds. The integration of publicly available chemical, or medical Big Data and artificial intelligence (AI)-based approaches led to qualitative and quantitative prediction of human PK of a candidate drug. However, predicting drug response with these approaches is challenging, partially because of the adaptation of algorithmic and limitations related to experimental data. In this report, we provide an overview of machine learning (ML)-based quantitative structure-activity relationship (QSAR) models used in the assessment or prediction of PK values as well as databases available for obtaining such data.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.